David Matthew T
Insider CIK 1811612 · ATNM Chief Financial Officer · CRMD Interim CEO and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-10-14 | 2026-10-16 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-10-14 | 2026-10-16 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2025-01-10 | 2025-01-14 | 6,515 | $11.19 | $72.9K | 95,270 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2025-01-02 | 2025-01-06 | 8,648 | $8.22 | $71.1K | 101,786 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2025-01-02 | 2025-01-06 | 62,500 | — | $0 | 110,434 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2024-01-12 | 2024-01-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2024-01-12 | 2024-01-17 | 50,000 | — | $0 | 53,150 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2024-01-12 | 2024-01-17 | 5,216 | $3.47 | $18.1K | 47,934 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2023-01-14 | 2023-01-18 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2022-02-18 | 2022-02-23 | 0 | — | $0 | 100,000 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2021-12-06 | 2021-12-07 | 1,000 | $4.50 | $4.5K | 3,150 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2021-12-06 | 2021-12-07 | 1,000 | $4.50 | $4.5K | 3,150 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2021-11-17 | 2021-11-19 | 1,000 | $5.07 | $5.1K | 2,150 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2021-11-01 | 2021-11-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CRMD | A Award deriv | 2021-01-11 | 2021-01-13 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2020-09-03 | 2020-09-08 | 1,150 | $4.07 | $4.7K | 1,150 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2020-05-11 | 2020-05-13 | 125,000 | $4.08 | $510.0K | 125,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2020-05-11 | 2020-05-13 | 125,000 | $5.63 | $703.8K | 125,000 | SEC↗ |